State
73,718 recalls have nationwide distribution and so reach Indiana. 9,596 additional recalls listed Indiana specifically in their distribution scope.
Of the 9,596 recalls naming Indiana we have scored against our rubric, 1,908 (20%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,534 (26%) are Severe.
Which agencies issued them
These figures cover only the 9,596 recalls whose distribution notice names Indiana specifically. The 73,718 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Calvin Scott & Co. is recalling Phentermine HCL capsules because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling Hydrochlorothiazide 25mg tablets because light-sensitive products were repackaged in transparent pouches.
Chembio Diagnostics is recalling 97 DPP Micro Reader II kits because the FDA revoked their Emergency Use Authorization due to performance issues.
Cytocell Ltd. is recalling NUP98 Distal Probe Green units due to a low risk of false positive results in laboratory testing.
Calvin Scott & Co. is recalling specific lots of Thyroid 1 Grain Tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
CareFusion 303, Inc. is recalling Alaris PCA Module Model 8120 units because the LED display may show dim segments, potentially affecting the visibility of infusion or patient monitoring values.
Calvin Scott & Co. is recalling specific lots of Phentermine HCL capsules because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
CareFusion 303, Inc. is recalling Alaris Syringe Module Model 8110 units because the LED display may show dim segments, potentially affecting the visibility of infusion or patient monitoring values.
Sanofi-Aventis is recalling 7,451 vials of Elitek (rasburicase) because routine stability testing showed enzyme activity levels were out of specification.
Calvin Scott & Co. is recalling Thyroid 1 Gr tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Co. is recalling specific lots of Phendimetrazine capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling specific lots of Phentermine HCL 37.5 mg tablets because they were repackaged in transparent pouches, violating light-sensitivity requirements.
Calvin Scott & Company is recalling Phentermine HCL 30mg capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling Phentermine 15mg capsules because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
Calvin Scott & Company is recalling specific lots of Phendimetrazine 35mg tablets because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling Thyroid Neutral Tabs 2 gr because light-sensitive tablets were repackaged in transparent pouches, violating CGMP standards.
Smith & Nephew is recalling 528 units of the Polarstem Collar Reamer Guide due to a product design issue. The devices were distributed worldwide and in the US.
Calvin Scott & Company is recalling specific lots of Phentermine HCL tablets because light-sensitive products were repackaged in transparent pouches.
Calvin Scott & Company is recalling specific lots of Phendimetrazine 35mg tablets because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
Calvin Scott & Company is recalling Phentermine HCL 30mg capsules because they were repackaged in transparent pouches, exposing the light-sensitive medication to potential degradation.
Calvin Scott & Company is recalling specific lots of Phentermine HCL tablets because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
Calvin Scott & Co. is recalling Hydrochlorothiazide 25mg tablets because light-sensitive products were repackaged in transparent pouches.
Shanghai United Imaging Healthcare Co., Ltd. is recalling three uMI 550 PET/CT systems because a software defect may prevent the CT Hounsfield unit curve from displaying in real time during specific scans.
Calvin Scott & Company is recalling Hydrochlorothiazide 50mg tablets because light-sensitive products were repackaged in transparent pouches, violating CGMP standards.
CareFusion 303, Inc. is recalling Alaris Pump Module Model 8100 units because LED display segments may appear dim, potentially affecting the visibility of infusion or patient monitoring values.